litlas
ログインアカウント作成

Daniel G. Anderson

1997–2025 年に発表

240
論文数
70,139
被引用数
139
h 指数
233
i10 指数

被引用数

Daniel G. Anderson の年別被引用数1990 年: 被引用 2 件1994 年: 被引用 4 件1998 年: 被引用 9 件1999 年: 被引用 5 件2000 年: 被引用 10 件2001 年: 被引用 9 件2002 年: 被引用 12 件2003 年: 被引用 19 件2004 年: 被引用 25 件2005 年: 被引用 67 件2006 年: 被引用 93 件2007 年: 被引用 109 件2008 年: 被引用 165 件2009 年: 被引用 220 件2010 年: 被引用 286 件2011 年: 被引用 378 件2012 年: 被引用 466 件2013 年: 被引用 442 件2014 年: 被引用 646 件2015 年: 被引用 793 件2016 年: 被引用 986 件2017 年: 被引用 1,095 件2018 年: 被引用 1,462 件2019 年: 被引用 3,106 件2020 年: 被引用 3,555 件2021 年: 被引用 3,849 件2022 年: 被引用 3,279 件2023 年: 被引用 3,159 件2024 年: 被引用 4,080 件2025 年: 被引用 2,461 件2026 年: 被引用 97 件1991〜1993 年は被引用が無いため表示していません1995〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,376 件、この内訳の 26.2%中国: 引用元論文 6,014 件、この内訳の 21.3%イギリス: 引用元論文 1,169 件、この内訳の 4.1%ドイツ: 引用元論文 1,151 件、この内訳の 4.1%韓国: 引用元論文 854 件、この内訳の 3%インド: 引用元論文 847 件、この内訳の 3%カナダ: 引用元論文 752 件、この内訳の 2.7%オーストラリア: 引用元論文 702 件、この内訳の 2.5%日本: 引用元論文 668 件、この内訳の 2.4%イタリア: 引用元論文 659 件、この内訳の 2.3%フランス: 引用元論文 599 件、この内訳の 2.1%オランダ: 引用元論文 589 件、この内訳の 2.1%
0%26.2%その他 24.2%

機関

分野

  • Biochemistry, Genetics and Molecular Biology50.3%
  • Medicine19.4%
  • Engineering8.1%
  • Materials Science7.7%
  • Immunology and Microbiology7.5%
  • Pharmacology, Toxicology and Pharmaceutics2.6%
  • その他4.4%

トピック

  • RNA Interference and Gene Delivery11.3%
  • Advanced biosensing and bioanalysis techniques6.6%
  • CRISPR and Genetic Engineering3.6%
  • Nanoparticle-Based Drug Delivery3.1%
  • Immunotherapy and Immune Responses2.5%
  • Virus-based gene therapy research2.5%
  • その他70.4%

共著者

全論文

検索で開く
  1. The clinical progress of mRNA vaccines and immunotherapies

    著者: Ann Barbier, Allen Yujie Jiang, Peng Zhang, Richard Wooster, Daniel G. Anderson - Nature Biotechnology 2022 被引用: 770

  2. Non-viral vectors for gene-based therapy

    著者: Hao Yin, Rosemary Kanasty, Ahmed A. Eltoukhy, Arturo J. Vegas, J. Robert Dorkin, Daniel G. Anderson - Nature Reviews Genetics 2014 被引用: 3,079

  3. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

    著者: Randall J. Platt, Sidi Chen, Yang Zhou, Michael J. Yim, Lukasz Swiech, H. Kempton, James E. Dahlman, Oren Parnas, Thomas Eisenhaure, Marko Jovanović, D. B. Graham, Siddharth Jhunjhunwala, Matthias Heidenreich, Ramnik J. Xavier, Robert Langer, Daniel G. Anderson, Nir Hacohen, Aviv Regev, Guoping Feng, Phillip A. Sharp, Feng Zhang - Cell 2014 被引用: 2,087

  4. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

    著者: Piotr S. Kowalski, Arnab Rudra, Lei Miao, Daniel G. Anderson - Molecular Therapy 2019 被引用: 1,086

  5. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

    著者: Lei Miao, Linxian Li, Yuxuan Huang, Derfogail Delcassian, Jasdave S. Chahal, Jinsong Han, Yunhua Shi, Kaitlyn Sadtler, Wenting Gao, Jiaqi Lin, Joshua C. Doloff, Róbert Langer, Daniel G. Anderson - Nature Biotechnology 2019 被引用: 701

  6. Engineering circular RNA for potent and stable translation in eukaryotic cells

    著者: R. Alexander Wesselhoeft, Piotr S. Kowalski, Daniel G. Anderson - Nature Communications 2018 被引用: 840

  7. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

    著者: Kevin Kauffman, J. Robert Dorkin, Jung Hoon Yang, Michael W. Heartlein, Frank DeRosa, Faryal F. Mir, Owen S. Fenton, Daniel G. Anderson - Nano Letters 2015 被引用: 768

  8. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

    著者: Bowen Li, Rajith S. Manan, Shun‐Qing Liang, Akiva G. R. Gordon, Allen Yujie Jiang, Andrew Varley, Guangping Gao, Róbert Langer, Wen Xue, Daniel G. Anderson - Nature Biotechnology 2023 被引用: 274

  9. Knocking down barriers: advances in siRNA delivery

    著者: Kathryn A. Whitehead, Róbert Langer, Daniel G. Anderson - Nature Reviews Drug Discovery 2009 被引用: 3,113

  10. Delivery materials for siRNA therapeutics

    著者: Rosemary Kanasty, J. Robert Dorkin, Arturo J. Vegas, Daniel G. Anderson - Nature Materials 2013 被引用: 1,782

  11. Strategies, design, and chemistry in siRNA delivery systems

    著者: Yizhou Dong, Daniel J. Siegwart, Daniel G. Anderson - Advanced Drug Delivery Reviews 2019 被引用: 573

  12. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

    著者: Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas, Philip Chang, Omid Veiseh, J. Matthews, Owen S. Fenton, Yunlong Zhang, Karsten Olejnik, Volkan Yesilyurt, Delai Chen, Scott Barros, Boris Klebanov, Tatiana I. Novobrantseva, Róbert Langer, Daniel G. Anderson - Nature Communications 2014 被引用: 617

  13. RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In Vivo

    著者: R. Alexander Wesselhoeft, Piotr S. Kowalski, Frances C. Parker-Hale, Yuxuan Huang, Namita Bisaria, Daniel G. Anderson - Molecular Cell 2019 被引用: 464

  14. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver

    著者: Lei Miao, Jiaqi Lin, Yuxuan Huang, Linxian Li, Derfogail Delcassian, Yifan Ge, Yunhua Shi, Daniel G. Anderson - Nature Communications 2020 被引用: 333

  15. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

    著者: Matthias A. Oberli, Andreas M. Reichmuth, J. Robert Dorkin, Michael J. Mitchell, Owen S. Fenton, Ana Jaklenec, Daniel G. Anderson, Róbert Langer, Daniel Blankschtein - Nano Letters 2016 被引用: 702

  16. Lipid-like materials for low-dose, in vivo gene silencing

    著者: Kevin T. Love, Kerry P. Mahon, Christopher G. Levins, Kathryn A. Whitehead, William Querbes, J. Robert Dorkin, June Qin, William Cantley, Liu Liang Qin, Timothy Racie, Maria Frank-Kamenetsky, Ka Ning Yip, Rene Alvarez, Dinah W.Y. Sah, Antonin de Fougerolles, Kevin Fitzgerald, Victor Koteliansky, Akin Akinc, Róbert Langer, Daniel G. Anderson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 被引用: 965

  17. Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium

    著者: Asha K. Patel, James C. Kaczmarek, Suman Bose, Kevin Kauffman, Faryal F. Mir, Michael W. Heartlein, Frank DeRosa, Robert Langer, Daniel G. Anderson - Advanced Materials 2019 被引用: 374

  18. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

    著者: Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg, Elizaveta S. Leshchiner, Valentina Busini, Naushad Hossain, Sergio Bacallado, David N. Nguyen, Jason Fuller, Rene Alvarez, Anna Borodovsky, Todd Borland, Rainer Constien, Antonin de Fougerolles, J. Robert Dorkin, K. N. Jayaprakash, Muthusamy Jayaraman, Matthias John, Victor Koteliansky, Muthiah Manoharan, Lubomir V. Nechev, June Qin, Timothy Racie, Denitza Raitcheva, Kallanthottathil G. Rajeev, Dinah W.Y. Sah, Jürgen Soutschek, Ivanka Toudjarska, Hans‐Peter Vornlocher, Tracy Zimmermann, Róbert Langer, Daniel G. Anderson - Nature Biotechnology 2008 被引用: 1,220

  19. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry

    著者: Bowen Li, Idris O. Raji, Akiva G. R. Gordon, Lizhuang Sun, Theresa M. Raimondo, Favour A. Oladimeji, Allen Yujie Jiang, Andrew Varley, Róbert Langer, Daniel G. Anderson - Nature Materials 2024 被引用: 187

  20. Combinatorial development of nebulized mRNA delivery formulations for the lungs

    著者: Allen Yujie Jiang, Jacob Witten, Idris O. Raji, Feyisayo Eweje, Corina MacIsaac, Sabrina Meng, Favour A. Oladimeji, Yizong Hu, Rajith S. Manan, Róbert Langer, Daniel G. Anderson - Nature Nanotechnology 2023 被引用: 162

  21. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics

    著者: James E. Dahlman, Kevin Kauffman, Yiping Xing, Taylor E. Shaw, Faryal F. Mir, Chloe C. Dlott, Róbert Langer, Daniel G. Anderson, Eric T. Wang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 323

  22. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA

    著者: Bowen Li, Allen Yujie Jiang, Idris Raji, Caroline Atyeo, Theresa M. Raimondo, Akiva G. R. Gordon, Luke H. Rhym, Tahoura Samad, Corina MacIsaac, Jacob Witten, Haseeb Mughal, Taras M. Chicz, Yue Xu, Ryan P. McNamara, Sangeeta N. Bhatia, Galit Alter, Róbert Langer, Daniel G. Anderson - Nature Biomedical Engineering 2023 被引用: 149

  23. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

    著者: Hyukjin Lee, Abigail K. R. Lytton‐Jean, Yi Chen, Kevin T. Love, Angela I. Park, Emmanouil D. Karagiannis, Alfica Sehgal, William Querbes, Christopher Zurenko, Muthusamy Jayaraman, Chang G. Peng, Klaus Charissé, Anna Borodovsky, Muthiah Manoharan, Jessica Donahoe, Jessica Truelove, Matthias Nahrendorf, Róbert Langer, Daniel G. Anderson - Nature Nanotechnology 2012 被引用: 1,172

  24. Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes

    著者: Owen S. Fenton, Kevin Kauffman, James C. Kaczmarek, Rebecca L. McClellan, Siddharth Jhunjhunwala, Mark W. Tibbitt, Manhao D. Zeng, Eric A. Appel, J. Robert Dorkin, Faryal F. Mir, Jung Hoon Yang, Matthias A. Oberli, Michael W. Heartlein, Frank DeRosa, Róbert Langer, Daniel G. Anderson - Advanced Materials 2017 被引用: 282